article thumbnail

The Definition of “Fully Vaccinated” Needs to Change

Eye on FDA

We are long gone from the days of being threatened by a rampant Alpha virus to having several successive variants. It would seem that Omicron has rendered that definition outmoded. The COVID-19 pandemic is a rapidly changing landscape. We now have multiple vaccines – mRNA and traditional in the U.S.

Vaccine 72
article thumbnail

Roche signs definitive share purchase agreement with long-term partner TIB.

The Pharma Data

Roche today announced that it has signed a definitive share purchase agreement to acquire 100% of the outstanding shares of the TIB Molbiol Group. The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use assays on Roche`s LightCycler PCR instruments.

Virus 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

#WhyIScience Q&A: A process development lead returns to her research roots

Broad Institute

After graduating, Teixeira-Soldano discovered new definitions of development that intrigued her. In this #WhyIScience, she talks about her role as a COVID-19 lab technician, how she transitioned into a process development role, and how her definition of development has changed throughout her career.

article thumbnail

CDC says nearly 11,000 Americans have been exposed to COVID-19 on flights

The Pharma Data

The agency says that a significant amount of the people exposed fell ill with the virus, but there could be more cases due to incomplete contact tracing information and the virus incubating over several days. This follows other studies in Asia and Europe where scientists believe the virus has spread on commercial flights.

Virus 52
article thumbnail

Coronavirus: Children's role in spread puzzles scientists

The Pharma Data

Earlier studies have found the vast majority of children with the virus have mild or no symptoms. But these findings shed light on the unresolved question of how likely children are to spread the virus to others. How severely do they get the virus? Do they pass it on to others? What does the South Korean study say?

Virus 52
article thumbnail

Regeneron’s COVID-19 Outpatient Trial Prospectively Demonstrates that REGN-COV2 Antibody Cocktail Significantly Reduced Virus Levels and Need for Further Medical Attention

The Pharma Data

Today’s data, involving an additional 524 patients from the ongoing Phase 2/3 trial, provides definitive final virology results and meets the clinical endpoint of reducing medical visits. In the overall patient group with detectable virus at baseline, the average daily reduction in viral load through day 7 was a 0.36

Virus 40
article thumbnail

Vaxzevria and mRNA COVID-19 vaccines showed similar and favourable safety profiles in a population-based cohort study of over a million people

The Pharma Data

No specific risk factors or definitive cause for TTS following COVID-19 vaccination have been identified and AstraZeneca continues to perform and support ongoing investigations of potential mechanisms. Furthermore, these very rare events can be managed when symptoms are identified and treated appropriately.

Vaccine 52